BPC-157 Dosage Guide

Complete guide to BPC-157 dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Typical research dosages range from 250-500mcg administered 1-2 times daily. Both subcutaneous and oral administration have been studied.

Administration Method

Can be administered subcutaneously near the injury site or systemically. Stable in gastric juice, making oral administration viable.

Side Effects to Monitor

Generally well-tolerated in research. Some reports of mild nausea or dizziness at higher doses.

Safety Considerations & Risks

Limited human clinical trial data. Long-term effects not well established. Not FDA approved for human use.